Answers are grounded in this paper and cite their sources.
Native bovine factor V exists in three forms of differing molecular size, the oligomeric interconvertible forms A and C and a phospholipid-containing complex designated form L. Thrombin increases the activity of form A to a greater extent than form L and does not alter the activity of form C. Thrombin-activated form A and form C function as potent inhibitors of thrombin activation of form A but cannot inhibit the action of thrombin on other substrates as α-N-toluene-sulfonyl-l-arginine methyl ester and fibrinogen. No change in the molecular size of any of these three forms was detected after exposure to thrombin. Factor V derived from serum by endogenous thrombin action appeared to have a smaller Stokes radius than that of form A, the predominant form in plasma. However, the serum factor V associates to a form similar in size to form A after storage in 50% glycerol. These results suggest the formation of a complex between these inhibitor forms of factor V and activated factor V (form A), suggesting that both substrate and product inhibition occur.
No takes yet. Share an insight, caveat, or question.
Colman et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: